Inositol , another key ingredient in MIC/B12 injections, is a type of sugar alcohol that is often associated with B-vitamins
Moreover, BPC157 increases vessel density both in vivo and in vitro (in living organisms and in laboratory test tubes respectively) and speeds the process of recovery of blood flow in ischemic muscle tissue
Possible causes: dead space accumulation (discussed above), inaccurate water volume at reconstitution (more water means more dilute, means more volume per dose, means fewer doses from the same amount of peptide), or air in the vial displacing solution
Gastrointestinal effects: the main titration bottleneck Nausea, diarrhea, constipation, and vomiting run around 40 to 44% overall, dose-dependent in how many people report them but mild-dominant in severity: severe events stay at or below about 1.7% in any category even at the top dose. In the obesity program the by-dose rates run nausea 25/29/28%, diarrhea 19/21/23%, and vomiting 8/11/13% at 5/10/15 mg. They concentrate during escalation and ease with time on a held dose